MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202527082894 A) filed by Oncoone Research & Development Gmbh, Klosterneuburg, Austria, on Sept. 1, for 'improved bispecific anti-tumor antigen/anti-hsg antibodies for pre-targeting of hyperproliferative disorders.'
Inventor(s) include Schinagl, Alexander; Mirkina, Irina; Puchol Tarazona, Alejandro; and Thiele, Michael Robert.
The application for the patent was published on Sept. 26, under issue no. 39/2025.
According to the abstract released by the Intellectual Property India: "The invention refers to a bispecific anti-tumor antigen/anti-HSG antibody with selected light and heavy chain variable domains which allows improved pre-targeting of tumors ...